Daiichi Sankyo introduces AD drug in Japan
Memary, an N-methyl-D-aspartate (NMDA) receptor antagonist, is the generic version of Memantine Hydrochloride, which was licensed from Merz Pharmaceuticals. Daiichi Sankyo has obtained the Japanese approval to manufacture
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.